Skip to content
healthfity logo Healthfity
healthfity logo Healthfity
  • Home
  • Health
  • Fitness
  • Lifestyle
  • Nutrition
  • Skin & Hair
  • Weight Loss
  • Home
  • Health
  • Fitness
  • Lifestyle
  • Nutrition
  • Skin & Hair
  • Weight Loss
Close

Search

Health

Blood Test for CTE: What 2026 Studies Show for Living Patients

Two peer-reviewed studies published in JAMA in November 2026 suggest that a blood test for CTE may help identify chronic traumatic encephalopathy (CTE) in living people. Right now, doctors can only confirm CTE by examining brain tissue after death, leading many former athletes, military veterans, and families to assume a routine lab draw is already available at a doctor’s office. In reality, the blood test remains an investigational research tool that primarily flags advanced stages of CTE rather than early symptoms, and it is not approved for clinical diagnosis.

Two November 2026 JAMA studies led by Boston University/Banner Health and Washington University in St. Louis found that elevated blood levels of a tau protein fragment called eMTBR-tau (or eMTBR-tau243) correlate with autopsy-confirmed CTE. The findings apply mainly to advanced-stage CTE in small research cohorts and are not yet validated or FDA-approved for individual patient testing. Former athletes and veterans experiencing memory or mood symptoms can still pursue thorough clinical evaluations today to rule out treatable conditions.

Football helmet, worn football, and blood sample tubes beside a seated athlete, illustrating research into blood tests for chronic traumatic encephalopathy (CTE).

Is There a Blood Test for CTE in Living Patients Right Now?

Not for routine medical care yet, though two studies published in JAMA in November 2026 showed promising progress. Researchers at Boston University and Washington University in St. Louis found that elevated blood levels of a specific tau protein fragment accurately identified advanced-stage CTE pathology in small human study groups, pending larger validation trials and regulatory review.

Historically, CTE could only be diagnosed post-mortem. According to National Institute of Neurological Disorders and Stroke (NINDS) consensus criteria, a definitive diagnosis requires examining brain tissue under a microscope to see abnormal phosphorylated tau proteins clustered around small blood vessels at the depths of brain folds (cortical sulci). Because living patients cannot undergo brain tissue biopsies for this condition, clinicians have had to rely on symptom history and exclusion of other illnesses.

As detailed in the Boston University Chobanian & Avedisian School of Medicine announcement, the newly identified blood biomarker is still in the discovery phase. You cannot order a CTE blood test at Quest, LabCorp, or a primary care clinic today, and the authors emphasize that larger autopsy and clinical validation studies are needed before the test can guide personal medical decisions.

What the Two November 2026 JAMA Studies Actually Show

Much of the confusion in news headlines comes from two separate JAMA papers being reported side by side. Both investigated fragments from the microtubule-binding region of tau (eMTBR-tau), a protein that forms abnormal tangles inside injured brain cells, but they examined different patient cohorts.

Study FeatureBoston University & Banner Health StudyWashington University in St. Louis Study
Publication datePublished November 19, 2026 in JAMA (PubMed abstract)Published November 13, 2026 in JAMA (PubMed abstract)
Biomarker measuredPlasma eMTBR-tauCerebrospinal fluid and plasma eMTBR-tau243
People studied21 former American football players who donated their brainsCohorts with mixed tauopathies, including autopsy-confirmed CTE
Main findingHigher blood eMTBR-tau levels associated with advanced CTE tau pathologyElevated eMTBR-tau243 distinguished advanced CTE from non-CTE controls
Primary limitationSmall sample size of mostly male football donors; requires larger cohortsLimited CTE case count; focused primarily on late-stage pathology

A key challenge in CTE biomarker research is separating CTE from Alzheimer’s disease, since both conditions involve abnormal tau buildup. In both studies, researchers addressed this overlap by looking at another blood marker called p-tau217. While p-tau217 rises sharply in Alzheimer’s disease, it generally remains low in people with isolated CTE. Combining a high eMTBR-tau reading with a negative Alzheimer’s biomarker profile helps researchers isolate CTE-specific pathology.

Why the Test Detects Advanced CTE—Not Early Stages

A major detail left out of many brief news summaries is that these blood biomarkers reliably detected advanced (high-stage) CTE rather than early disease.

In neuropathology, CTE is typically graded from Stage I (mild, localized tau deposits) to Stage IV (widespread tau tangles and brain tissue shrinkage). In the November 2026 studies, blood levels of eMTBR-tau rose significantly in donors with advanced CTE pathology, whereas low-stage CTE released too little of the protein fragment into the bloodstream to separate reliably from people without CTE.

For readers, this distinction carries two practical takeaways:

  • Who the findings apply to: The current evidence applies primarily to older individuals with heavy, cumulative head-impact exposure and advanced neurodegenerative pathology.
  • Who the findings do not apply to: A future blood test based on these markers would not rule out early-stage brain changes in a 25- or 35-year-old athlete or veteran experiencing mild mood or attention difficulties.

Acute Concussion Blood Tests vs. Chronic CTE Blood Tests

Many people assume a CTE blood test already exists because emergency rooms in the United States use FDA-cleared blood tests for head injuries. Those hospital tests measure completely different brain proteins and answer a different medical question.

FeatureFDA-Cleared Acute TBI Blood TestsExperimental CTE Blood Test
ExamplesAbbott i-STAT TBI; Banyan Brain Trauma IndicatorInvestigational plasma eMTBR-tau / eMTBR-tau243 assays
Proteins measuredGFAP and UCH-L1eMTBR-tau fragments (paired with p-tau217)
When it is usedWithin 12 to 24 hours after an acute blow to the headYears after repetitive head impacts end
Clinical purposeHelps ER doctors decide whether a head CT scan is needed to check for acute brain bleedingInvestigated to detect chronic tau tangle pathology during life
AvailabilityFDA-cleared for hospital and clinical lab useResearch-only; not FDA-cleared

According to the FDA review summary for the i-STAT TBI test, acute TBI blood tests check for sudden cellular injury right after a concussion or fall. They cannot detect delayed, long-term tau accumulation associated with CTE.

What Doctors Can Evaluate Today If You Have Symptoms

Waiting years for an FDA-approved CTE blood test does not mean former athletes, military veterans, or families have to ignore concerning symptoms. As noted in the CDC Traumatic Brain Injury and Concussion symptom guide, difficulties with memory, concentration, irritability, depression, headaches, and sleep overlap heavily with common, treatable health conditions.

When clinicians evaluate living patients with a history of repetitive head impacts, they often use research frameworks such as Traumatic Encephalopathy Syndrome (TES) alongside a thorough workup to identify reversible causes. A practical evaluation generally involves four steps:

  1. See a specialist in brain injury or behavioral neurology: Ask your primary care doctor for a referral to a behavioral neurologist or a multidisciplinary concussion clinic. Military veterans can request an evaluation through the Veterans Health Administration Polytrauma/TBI System of Care.
  2. Complete formal neuropsychological testing: A neuropsychologist administers standardized pen-and-paper and digital tests to measure memory, attention, processing speed, and executive function, creating an objective baseline.
  3. Rule out structural and metabolic look-alikes: Doctors typically order a standard brain MRI to check for strokes, tumors, or other structural issues, alongside routine blood tests for thyroid function, vitamin B12 levels, and hormone imbalances.
  4. Screen for sleep disorders and mood conditions: Untreated obstructive sleep apnea, chronic pain, major depression, and post-traumatic stress disorder (PTSD) frequently cause severe brain fog and irritability after sports or military careers—and all respond to targeted medical treatment.

Questions to ask at your appointment:

  • Which of my current symptoms could be caused by treatable conditions like sleep apnea, depression, or medication side effects?
  • Would a formal neuropsychological baseline test help track my memory and focus over the next year?
  • Are there observational brain-health studies or clinical registries for former athletes or veterans that I qualify to join?

Seek urgent medical care right away if anyone with a history of head trauma develops sudden weakness or numbness, slurred speech, seizures, severe worsening headaches, or acute thoughts of self-harm.

Frequently Asked Questions

Can a blood test diagnose CTE while you are alive?

Currently, CTE can only be confirmed after death through a neuropathological exam of brain tissue. Two November 2026 JAMA studies found that an investigational blood biomarker called eMTBR-tau correlates with advanced CTE pathology during life, but larger clinical trials are required before doctors can use it for diagnosis.

When will the CTE blood test be available to the public?

There is no confirmed public release date. Because the November 2026 studies involved small discovery cohorts, researchers must validate the test across larger, more diverse populations and obtain U.S. Food and Drug Administration (FDA) clearance before commercial laboratories or clinics can offer it.

Can you develop CTE without ever having a diagnosed concussion?

Yes. Research cited by the National Institute of Neurological Disorders and Stroke indicates that CTE is most strongly associated with cumulative, repetitive head impacts over years—including routine sub-concussive hits in contact sports or military blast exposure—rather than a single diagnosed concussion.

How do researchers tell CTE apart from Alzheimer’s disease in blood?

Both CTE and Alzheimer’s disease involve abnormal tau protein accumulation, which can elevate eMTBR-tau levels. Researchers distinguish the two by measuring a second marker called p-tau217, which rises significantly in Alzheimer’s disease but typically remains low in people who have CTE without Alzheimer’s.

Are there any blood tests for concussions that are FDA-approved right now?

Yes, the FDA has cleared emergency-room blood tests—such as the Abbott i-STAT TBI and Banyan Brain Trauma Indicator—that measure GFAP and UCH-L1 proteins within 12 to 24 hours of a head injury. Those tests help clinicians decide whether a patient needs a CT scan to check for acute brain bleeding, not chronic CTE.

Author

Devid

Follow Me
Other Articles
Child viewed from behind with a translucent anatomical visualization of the lungs and immune system, illustrating measles-related respiratory infection and airborne exposure.
Previous

Virginia 2026 Pediatric Measles Death: Case Facts & Child Safety

Scientific visualization of the female reproductive system alongside a glowing DNA helix, illustrating genetic research into endometriosis and associated risk regions.
Next

Endometriosis Genetic Study 2026: 58 New Risk Regions Found

No Comment! Be the first one.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

About This Site

Healthfity — We share simple, easy-to-understand information about health, fitness, nutrition, lifestyle, skin and hair care, and healthy living.

Search

Recent Posts

  • Texas Flu Surge 2026: CDC Map, Symptoms & Prevention
  • Cancer mRNA Vaccines 2026: Trial Results & Approval Timeline
  • Mutated Flu Strain 2026: CDC Data, Symptoms & Vaccine Fit
  • Daraxonrasib for Pancreatic Cancer: What 2026 Studies Show
  • Endometriosis Genetic Study 2026: 58 New Risk Regions Found

You May Have Missed

A woman receiving a flu vaccination from a healthcare worker in a clinic, illustrating Texas flu shot recommendations for 2026.
Health

Texas Flu Surge 2026: CDC Map, Symptoms & Prevention

Devid
By Devid
November 22, 2026
Laboratory researcher handling samples beside a microscope and cancer cell imagery, representing research into cancer mRNA vaccines and clinical trials.
Health

Cancer mRNA Vaccines 2026: Trial Results & Approval Timeline

Devid
By Devid
November 22, 2026
Person resting at home with a blanket, tissues, lemon tea, and thermometer, illustrating flu symptoms and seasonal influenza concerns.
Health

Mutated Flu Strain 2026: CDC Data, Symptoms & Vaccine Fit

Devid
By Devid
November 22, 2026
Scientific visualization of pancreatic cancer showing a tumor in the pancreas alongside laboratory research equipment, illustrating studies of daraxonrasib as a potential cancer treatment.
Health

Daraxonrasib for Pancreatic Cancer: What 2026 Studies Show

Devid
By Devid
November 22, 2026
Scientific visualization of the female reproductive system alongside a glowing DNA helix, illustrating genetic research into endometriosis and associated risk regions.
Health

Endometriosis Genetic Study 2026: 58 New Risk Regions Found

Devid
By Devid
November 22, 2026
Blood sample tubes in a medical research laboratory with a brain scan in the background, illustrating research into blood tests for chronic traumatic encephalopathy (CTE).
Health

Blood Test for CTE: What 2026 Studies Show for Living Patients

Devid
By Devid
November 22, 2026
Child viewed from behind with a translucent anatomical visualization of the lungs and immune system, illustrating measles-related respiratory infection and airborne exposure.
Health

Virginia 2026 Pediatric Measles Death: Case Facts & Child Safety

Devid
By Devid
November 22, 2026
3 Charged After Child Undergoes Unnecessary Surgery in West Virginia
Health

3 Charged After Child Undergoes Unnecessary Surgery in West Virginia

Devid
By Devid
November 19, 2026
Aging Slows the Brain’s Nighttime Cleaning System
Lifestyle

Aging Slows the Brain’s Nighttime Cleaning System

Devid
By Devid
November 19, 2026

About This Site

Healthfity — We share simple, easy-to-understand information about health, fitness, nutrition, lifestyle, skin and hair care, and healthy living.

Recent Posts

  • Texas Flu Surge 2026: CDC Map, Symptoms & Prevention
  • Cancer mRNA Vaccines 2026: Trial Results & Approval Timeline

Important Links

  Privacy Policy

  Terms & Conditions

  Disclaimer

  Contact Us

Contact Us

contact@healthfity.com

Copyright 2026 — Healthfity. All rights reserved

Website security powered by MilesWeb